|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R5
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Contents
SUMMARY
1
INTRODUCTION
2
THE CARRYOVER ISSUE IN SECTION 317 EXPENDITURES
5
THE IMPACT OF THE STATE CHILDREN'S HEALTH INSURANCE PROGRAM
7
NEXT STEPS
9
REFERENCES
11
NOTES
12
APPENDIXES
14
Table 1
Annual Awards and Expenditures of Section 317 Direct Assistance (DA Vaccine Purchase Funds (in millions),
15
Table 2
Annual Awards and Expenditures of Section 317 Financial Assistance (FA) Immunization Program Funds (in millions),
16
Figure 1
Amount of New Funding Awarded as Section 317 Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,
17
Figure 2
Amount of Total Annual Awards of Section 317 Funds, Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,
17
Figure 3
Section 317 Grant Allocations from CDC to State and Local Immunization Programs, 1988–1999,
18
COMMITTEE BIOGRAPHIES
19